ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO099

Effect of 3% Saline and Furosemide on Biomarkers of Kidney Injury and Renal Tubular Function and GFR in Healthy Subjects: A Randomized Controlled Trial

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Mose, Frank H., Hospital Unit West Jutland, Holstebro, Denmark
  • Vrist, Marie Houmaa, Hospital Unit West Jutland, Holstebro, Denmark
  • Bech, Jesper N., Hospital Unit West Jutland, Holstebro, Denmark
Background


Chloride is speculated to have nephrotoxic properties. In healthy subjects we tested the hypothesis that acute chloride loading with 3 % saline would induce kidney injury, which could be prevented with furosemide.

Methods


The study was designed as a randomized, placebo-controlled, crossover study. Subjects were given 3 % saline accompanied by either placebo or furosemide. Before, during and after infusion of 3 % saline we measured GFR, fractional excretion of sodium (FENa), urinary chloride excretion (u-Cl), urinary excretions of aquaporin-2 (u-AQP2), neutrophil gelatinase-associated lipocalin (u-NGAL) and kidney injury molecule-1 (u-KIM-1) as marker of kidney injury and vasoactive hormones: renin (PRC), angiotensin II (p-AngII), aldosterone (p-Aldo) and arginine vasopressin (p-AVP). Four days prior to each of the two examinations subjects were given a standardized diet and fluid intake.

Results

After 3% saline infusion u-NGAL and KIM-1 excretion increased slightly (u-NGAL: 17+/- 24 during placebo vs. -7 +/- 23 ng/min during furosemide, p=0.039, u-KIM-1: 0.21 +/- 0.23 vs -0.06 +/- 0.14 ng/ml, p<0.001). The increase in NGAL was absent when furosemide was given simultaneously, and the responses in NGAL were not significantly different from placebo control. Furosemide changed responses in KIM-1 where a delayed increase was observed.
GFR was increased by 3 % saline but decreased when furosemide accompanied the infusion. U-Na, FENa, u-Cl, and u-osmolality increased in response to saline, and the increase was markedly pronounced when furosemide was added. FEK decreased slightly during 3 % saline infusion, but simultaneously furosemide increased FEK.U-AQP2 increased after 3 % saline and placebo, and the response was further increased by furosemide. 3 % saline significantly reduced PRC, p-AngII and p-Aldo, and responses were attenuated by furosemide. p-AVP was increased by 3 % saline, with a larger increase during furosemide.

Conclusion

This study shows minor increases in markers of kidney injury after 3% saline infusion Furosemide abolished the increase in NGAL and postponed the increase in u-KIM-1. The clinical importance of these findings needs further investigation.

Funding

  • Government Support - Non-U.S.